Colchicine use during breastfeeding

Breastfeed Med. 2015 Mar;10(2):92-5. doi: 10.1089/bfm.2014.0086. Epub 2015 Feb 3.


Objective: This study evaluated the outcome of infants exposed to colchicine during lactation.

Subjects and methods: A prospective observational cohort study design was used. Mothers who contacted Beilinson Teratology Information Service (BELTIS) regarding use of colchicine while breastfeeding were followed up by phone interview. Data on lactation, neonatal symptoms, and outcome 1-3 years after initial consultation were obtained. Mothers breastfeeding while taking colchicine (n=37) and their infants (n=38) were compared with a matched control group of mothers using a drug known to be safe during lactation (n=75) and their infants (n=76).

Results: Follow-up was obtained for 59 of 76 (78%) women who contacted BELTIS regarding use of colchicine. Of the 59 women, 37 breastfed while taking colchicine, five did not take colchicine, 16 did not breastfeed, and one declined to participate. The mean duration of breastfeeding was similar in both groups. Adverse neonatal symptoms were seen in three of 38 colchicine-exposed infants versus four of 76 of control group infants (p=0.68). Delayed development or neurological abnormalities were seen in two infants in both study groups (p=0.60). None of the colchicine-exposed infants showed abnormal growth.

Conclusions: No increase in adverse long-term outcomes was found in colchicine-exposed breastfed infants. Our data support continuation of breastfeeding in women treated with colchicine.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Breast Feeding*
  • Colchicine / administration & dosage*
  • Colchicine / adverse effects
  • Drug Administration Schedule
  • Familial Mediterranean Fever / drug therapy*
  • Female
  • Gout Suppressants / administration & dosage*
  • Gout Suppressants / adverse effects
  • Humans
  • Infant
  • Infant, Newborn
  • Lactation / drug effects*
  • Milk, Human / chemistry
  • Milk, Human / drug effects*
  • Mothers
  • Pregnancy
  • Prospective Studies
  • Risk Assessment


  • Gout Suppressants
  • Colchicine